Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP is a generic product labeled by Actavis Pharma, Inc., priced at $0.8016 per EA under NDC 00591322001. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jul 30, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP
Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateStrength
325; 50; 40; 30 mg/1; mg/1; mg/1; mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591322001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020232FDA Approved
7/30/1992
TE Code
AB
On Market Since
9/18/2003
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 222.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8016 per EA |
|---|---|
| All-time high | $1.1376 (Aug 12, 2015) |
| All-time low | $0.2490 (Nov 28, 2013) |
| 52-week high | $0.9086 |
| 52-week low | $0.7990 |
| Median price | $0.8928 |
| Average price | $0.8662 |
| Largest weekly change | +45.9% (Jul 23, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP, manufactured by Actavis Pharma, Inc., is $0.8016 per EA (NDC 00591322001), effective Aug 19, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has risen 222.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
Since Nov 28, 2013, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP has ranged from a low of $0.2490 (Nov 28, 2013) to a high of $1.1376 (Aug 12, 2015), with a median of $0.8928 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
No other NADAC-published product currently shares the active ingredient and strength of BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP (NDC 00591322001) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.